Ophthalmology Innovation Source

Ophthalmology Innovation Source OIS is the optimal resource for meaningful interactions and information exchange between clinical, ca

12/24/2021
PENDING
12/08/2021

PENDING

Just 1 day until the OIS Drug Delivery Innovation Showcase, join us!*Registration is complimentary*Fore a sneak peek int...
12/01/2021

Just 1 day until the OIS Drug Delivery Innovation Showcase, join us!

*Registration is complimentary*

Fore a sneak peek into the agenda and registration click here ➡️ https://lnkd.in/e3H-G_2W

November is Diabetic Eye Disease Awareness month.About 40-45% of diabetics already have diabetic retinopathy, but only h...
11/16/2021

November is Diabetic Eye Disease Awareness month.

About 40-45% of diabetics already have diabetic retinopathy, but only half of them know it. Early Detection Of Diabetic Eye Diseases can reduce risk for blindness by 95%.

Share to spread awareness.

#

Feast your eyes on OIS Weekly, a weekly dose of innovation.Join the OIS community and keep an eye on innovation by subsc...
11/15/2021

Feast your eyes on OIS Weekly, a weekly dose of innovation.

Join the OIS community and keep an eye on innovation by subscribing today here ➡️ https://bit.ly/3HkK2KV

Adrienne Graves leads a panel that dives into what’s new and what’s next in   innovation, how panelists’ companies perse...
11/10/2021

Adrienne Graves leads a panel that dives into what’s new and what’s next in innovation, how panelists’ companies persevere through the COVID-19 pandemic, and more.

To watch, visit https://lnkd.in/epKa8AfG

To subscribe to the OIS Podcast, visit https://apple.co/3CqUHAE.

PODCAST EPISODE 305

11/01/2021

Don't miss candid conversations with Ophthalmology's innovators and business leaders every Wednesday🎙️

Subscribe today!

https://apple.co/3CqUHAE

Ramin Valian helped launch every one of Allergan’s glaucoma products. What fuels his passion? What’s next for Allergan? ...
10/27/2021

Ramin Valian helped launch every one of Allergan’s glaucoma products. What fuels his passion? What’s next for Allergan?

To find out, listen to the latest OIS podcast @ https://ois.net/change-creates-opportunity/

Three Pharma Plays in Gene Therapy Within nine days in September, three large pharmaceutical companies—AbbVie, Théa, and...
10/20/2021

Three Pharma Plays in Gene Therapy

Within nine days in September, three large pharmaceutical companies—AbbVie, Théa, and Novartis—initiated moves to foster the development of gene therapies for a host of retinal disorders. Read the full article in link below as we dive into the details of the three deals.

https://ois.net/nine-days-in-september-three-pharma-plays-in-gene-therapy/

Tom Ruggia introduces the SING IMT  Retina.Thank you to our sponsors, speakers, presenters and participants for making t...
10/14/2021

Tom Ruggia introduces the SING IMT Retina.

Thank you to our sponsors, speakers, presenters and participants for making this an amazing event!

Address

1 Huntington Quadrangle
Melville, NY
11747

Telephone

(516) 765-9005

Alerts

Be the first to know and let us send you an email when Ophthalmology Innovation Source posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Our Story

The Ophthalmology Innovation Summits facilitate meaningful interactions and the exchange of information between clinical, capital and corporate leaders to accelerate the development and commercialization of novel therapies to address unmet needs.